Opening book details…
About this Medicine article
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer by Wehler, Thomas; Thomas, Michael; Schumann, Christian; Bosch-Barrera, Joaquim; Viñolas Segarra, Nuria; Dickgreber, Nicolas J.; Dalhoff, Klaus; Sebastian, Martin; Corral Jaime, Jesus; Alonso, Miriam; Hynes, Scott M.; Lin, Ji; Hurt, Karla; Bence Lin, Aimee; Calvo, Emiliano; Paz-Ares, Luis is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Wehler, Thomas; Thomas, Michael; Schumann, Christian; Bosch-Barrera, Joaquim; Viñolas Segarra, Nuria; Dickgreber, Nicolas J.; Dalhoff, Klaus; Sebastian, Martin; Corral Jaime, Jesus; Alonso, Miriam; Hynes, Scott M.; Lin, Ji; Hurt, Karla; Bence Lin, Aimee; Calvo, Emiliano; Paz-Ares, Luis
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)